ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 328130 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 328130; 2) Community: the network communities that were significantly associated with the response to NSC 328130; 3) Molecule: the relationships between components within communities and NSC 328130; 4) MDR: the compounds that were significantly associated with the NSC 328130.

NSC Compound Enrichment Correlation
NSC 174121 Methotrexate Derivative 0.00845932736945076 0.54110707
NSC 19441 FDA 0283 0.009562217715459 0.36837977
NSC 705930 Null 0.00956221771545914 0.15732556
NSC 730254 Null 0.00956221771545914 -0.2028494
NSC 91745 9H-Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]-9-.beta.-D-ribofuranosyl-, compd. with ethyl alcohol (4:1) 0.00956221771545914 0.15900021
NSC 139105 Soluble Baker's Antifol 0.00970780973624031 0.37108261
NSC 176507 Fastigilin C 0.00970780973624031 0.25120032
NSC 258625 Null 0.00970780973624031 0.31044073
NSC 364170 3,13-Ethano-1H,10H-furo[3,4-c]furo[2',3':6,7]naphtho[2,3-b]pyran-3(3aH)-carboxylic acid, 4,5,6a,7,7a,8,12a,13-octahydro-4,14,15-trihydroxy-8,12a-dimethyl-5,10-dioxo-, methyl ester, [3S-(3.alpha.,3a.a 0.00970780973624031 -0.050696499
NSC 46728 Crassin acetate 0.00970780973624031 0.15303509
Total:86  Current:21    [First] [Prev] [Next] [Last]